Relay Therapeutics (RLAY) EPS (Basic) (2020 - 2025)
Historic EPS (Basic) for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to -$0.43.
- Relay Therapeutics' EPS (Basic) rose 3174.6% to -$0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.72, marking a year-over-year increase of 3409.96%. This contributed to the annual value of -$2.36 for FY2024, which is 1527.32% up from last year.
- As of Q3 2025, Relay Therapeutics' EPS (Basic) stood at -$0.43, which was up 3174.6% from -$0.41 recorded in Q2 2025.
- Relay Therapeutics' EPS (Basic)'s 5-year high stood at -$0.41 during Q2 2025, with a 5-year trough of -$2.1 in Q2 2021.
- Moreover, its 5-year median value for EPS (Basic) was -$0.62 (2024), whereas its average is -$0.68.
- Data for Relay Therapeutics' EPS (Basic) shows a peak YoY increase of 7801.24% (in 2021) and a maximum YoY decrease of 17490.69% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Relay Therapeutics' EPS (Basic) stood at -$0.62 in 2021, then grew by 11.29% to -$0.55 in 2022, then decreased by 21.82% to -$0.67 in 2023, then rose by 20.6% to -$0.53 in 2024, then increased by 19.17% to -$0.43 in 2025.
- Its EPS (Basic) was -$0.43 in Q3 2025, compared to -$0.41 in Q2 2025 and -$0.46 in Q1 2025.